Lilly’s Ebglyss Delivers 4-Year Disease Control in...
Category : Product Related Updates 31 March 2026Long-term consistency is rare in eczema treatment. Eli Lilly and Company just shared new data showin...
Long-term consistency is rare in eczema treatment. Eli Lilly and Company just shared new data showin...
Eisai Co., Ltd. will present new research on Lecanemab, its therapy for Alzheimer's disease, at...
Altamira Therapeutics announced that its associate company, Altamira Medica, has received a notice o...
New real-world research presented at the AAAAI Annual Meeting suggests that glucagon-like peptide-1...
NuLiv Science has released results from a new preclinical study evaluating AstraGin®, its patent...